Considered and approved unaudited financial result for the quarter and half year ended 30.09.2025 along with limited review report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Choksi Laboratories, an analytical testing and calibration lab group based in Indore, posted its H1 FY26 results. Revenue from operations rose to ₹1,111.71 lakh in Q2 from ₹926.22 lakh a year ago, a roughly 20% jump; H1 revenue grew to ₹2,235.90 lakh from ₹1,999.86 lakh (about 12%). Net profit for Q2 more than tripled to ₹24.21 lakh from ₹7.55 lakh, while H1 profit rose about 26% to ₹62.71 lakh from ₹49.62 lakh. Total expenses scaled up in line with revenue, with employee costs and depreciation being the largest line items. The auditor (Prateek Jain & Co) gave a clean limited review with no qualifications or concerns flagged. The balance sheet shows total borrowings of about ₹2,856 lakh (long-term ₹1,452L + short-term ₹1,404L) against shareholder equity of about ₹2,449 lakh. Operating cash flow fell sharply to ₹266.71 lakh from ₹559.53 lakh in the prior H1, mainly due to higher working capital outflows.
Strong top-line and bottom-line growth signals improving business momentum, but debt now exceeds equity (D/E roughly 1.17x) and weakening operating cash conversion despite higher profits warrants attention. Stock may get a modest positive read on growth, though balance sheet leverage remains a watchpoint.